ARTICLE | Company News
Seres Therapeutics, Mayo Clinic deal
June 13, 2016 7:00 AM UTC
Seres and Mayo Clinic’s Center for Individualized Medicine partnered to identify microbiome therapeutics for primary sclerosing cholangitis (PSC), non-alcoholic steatohepatitis (NASH) and other liver ...